Publications by authors named "George D Maynard"

Claim this Profile
N
Nogo receptor decoy promotes recovery and corticospinal growth in non-human primate spinal cord injury.
Xingxing Wang, Tianna Zhou, George D Maynard, Pramod S Terse, William B Cafferty

Brain· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rescue of Transgenic Alzheimer's Pathophysiology by Polymeric Cellular Prion Protein Antagonists.
Erik C Gunther, Levi M Smith, Mikhail A Kostylev, Timothy O Cox, Adam C Kaufman, George D Maynard

Cell Rep· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rescue of Transgenic Alzheimer's Pathophysiology by Polymeric Cellular Prion Protein Antagonists.
Erik C Gunther, Levi M Smith, Mikhail A Kostylev, Timothy O Cox, Adam C Kaufman, George D Maynard

Cell Rep· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The newly developed CRF1-receptor antagonists, NGD 98-2 and NGD 9002, suppress acute stress-induced stimulation of colonic motor function and visceral hypersensitivity in rats.
Mulugeta Million, Jing-Fang Zhao, Andrew Luckey, József Czimmer, George D Maynard

PLoS One· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting memory processes with drugs to prevent or cure PTSD.
Christopher K Cain, George D Maynard, John H Kehne

Expert Opin Investig Drugs· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of N-(1-ethylpropyl)-[3-methoxy-5-(2-methoxy-4-trifluoromethoxyphenyl)-6-methyl-pyrazin-2-yl]amine 59 (NGD 98-2): an orally active corticotropin releasing factor-1 (CRF-1) receptor antagonist.
Kevin J Hodgetts, Ping Ge, Taeyoung Yoon, Stéphane De Lombaert, Robbin Brodbeck, George D Maynard

J Med Chem· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emergence of anti-conflict effects of zolpidem in rhesus monkeys following extended post-injection intervals.
James K Rowlett, John H Kehne, Ken J Sprenger, George D Maynard

Psychopharmacology (Berl)· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and characterization of NDT 9513727 [N,N-bis(1,3-benzodioxol-5-ylmethyl)-1-butyl-2,4-diphenyl-1H-imidazole-5-methanamine], a novel, orally bioavailable C5a receptor inverse agonist.
Robbin M Brodbeck, Daniel N Cortright, Andrzej P Kieltyka, Jianying Yu, Carolyn O Baltazar, George D Maynard

J Pharmacol Exp Ther· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aminopyrazine CB1 receptor inverse agonists.
David J Wustrow, George D Maynard, Jun Yuan, He Zhao, Jianmin Mao

Bioorg Med Chem Lett· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis